Germline mutations in CDH1, the gene coding for the E-cadherin adhesion protein, are known to cause hereditary diffuse gastric cancer. We identified a new truncating germline mutation (p.Asp538Thrfs*19) in exon 11 of the CDH1 gene in a 41-year-old male with a diffuse gastric cancer. Although he had no parental history of gastric cancer, the co-segregation study in the family detected the same mutation in his healthy 31-year-old brother. The mutation affects one of the extracellular repeat (CAD repeats) domains which is essential for the homophilic binding specificity that directs E-cadherin to bind with itself each others. In this case, immunohistochemical analysis showed no expression of E-cadherin in the tumor sample and was a useful prescreening tool to genetic testing. This finding was associated with a poor response to trastuzumab-based treatment.
A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach / Caggiari, Laura; Miolo, Gianmaria; Canzonieri, Vincenzo; De Zorzi, Mariangela; Alessandrini, Lara; Corona, Giuseppe; Cannizzaro, Renato; Santeufemia, Davide Adriano; Cossu, Antonio; Buonadonna, Angela; De Re, Valli. - In: CANCER BIOLOGY & THERAPY. - ISSN 1538-4047. - 19:4(2018), pp. 254-259. [10.1080/15384047.2017.1394540]
A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
Canzonieri, Vincenzo;Cannizzaro, Renato;
2018-01-01
Abstract
Germline mutations in CDH1, the gene coding for the E-cadherin adhesion protein, are known to cause hereditary diffuse gastric cancer. We identified a new truncating germline mutation (p.Asp538Thrfs*19) in exon 11 of the CDH1 gene in a 41-year-old male with a diffuse gastric cancer. Although he had no parental history of gastric cancer, the co-segregation study in the family detected the same mutation in his healthy 31-year-old brother. The mutation affects one of the extracellular repeat (CAD repeats) domains which is essential for the homophilic binding specificity that directs E-cadherin to bind with itself each others. In this case, immunohistochemical analysis showed no expression of E-cadherin in the tumor sample and was a useful prescreening tool to genetic testing. This finding was associated with a poor response to trastuzumab-based treatment.| File | Dimensione | Formato | |
|---|---|---|---|
|
208302_OA.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
1.02 MB
Formato
Adobe PDF
|
1.02 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


